Organisation paid for research Program year 2024 Source: CMS Open Payments

Quantum Leap Health Care Collaborative

Neither a doctor nor a teaching hospital

Research payments

$22,768,764

171 payments

Through program year 2024, Quantum Leap Health Care Collaborative is reported as receiving $22,768,764 in research payments, across 171 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$15,394,428	2
2022	Research	$909,531	111
2021	Research	$246,274	31
2020	Research	$728,530	18
2019	Research	$5,490,000	9

Breakdown

Who paid Research payments · program years 2019–2024

GlaxoSmithKline, LLC. $16,625,764 160 payments
Dynavax Technologies Corporation $5,490,000 9 payments
Takeda Pharmaceuticals U.S.A., Inc. $653,000 2 payments

Studies the money was for Research payments · program years 2019–2024

0000000000000000000000000000000000000000000000000000000000000000223708 $15,394,428 2 payments
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY 2) $5,490,000 9 payments
0000000000000000000000000000000000000000000000000000000000000000214639 $1,155,806 142 payments
214639 $75,530 16 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.